BARCELONA, Spain--(BUSINESS WIRE)--Massive Bio, a global leader in artificial intelligence (AI) for cancer clinical trial enrollment, has announced the launch of Patient Connect, an innovative and ...
Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its ...
Pancreatic ductal adenocarcinoma (PDAC) is notoriously difficult to treat due to its aggressive nature and limited prognostic tools. While the traditional staging systems, such as the TNM ...
Mo Khalil is the Hok Lam and Kathleen Kam Wong Professor of Bioengineering and Professor of Molecular and Cellular Biology at ...
Research Areas: Cancer Pathobiology & Immunology, Cancer Genomics, Metabolomics, & Epigenetics, Carcinogenesis & Tumor Microenvironment, Metastasis & Experimental Therapeutics, Cancer Cell Biology & ...
This week, I address pushback I received on my Novartis-MorphoSys column. But first, a preview of the expected readout from Gritstone Bio’s neoantigen cancer vaccine study. Before the end of the ...
NEW YORK--(BUSINESS WIRE)--Massive Bio, a globally recognized leader in the oncology space, has proudly announced its appointment as a founding member of CancerX, a groundbreaking initiative endorsed ...
Tulane Ventures has invested $125,000 in Beken Bio, a biotechnology startup developing early-detection blood tests for aggressive cancers, bringing the company’s founder back to New Orleans as it ...
The goal of the Master of Science in Cancer Biology program is to provide an understanding of the fundamentals of cancer from an interdisciplinary perspective, including: biology and molecular biology ...
FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) -The U.S. health regulator will not meet its Dec. 16 deadline to decide on the expanded use of Bristol Myers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback